Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.780 +0.070 (+1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,982,318
Open 3.680
Bid (Size) 3.750 (2,600)
Ask (Size) 3.790 (100)
Prev. Close 3.710
Today's Range 3.680 - 3.780
52wk Range 3.680 - 8.400
Shares Outstanding 103,119,010
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ardelyx to Participate in Upcoming Investor Conferences
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
ARDX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ardelyx (ARDX)
From Levi & Korsinsky, LLP
Via Business Wire

Performance

YTD
-38.5%
-38.5%
1 Month
-23.0%
-23.0%
3 Month
-32.0%
-32.0%
6 Month
-38.9%
-38.9%
1 Year
-42.5%
-42.5%

More News

Read More
News headline image
Ardelyx (ARDX) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Economy
Ardelyx (NASDAQ:ARDX) Plunges After Q2 Miss and Guidance Cut ↗
Via Chartmill
Ardelyx Inc (NASDAQ:ARDX) Reports Strong Q1 Revenue Beat as IBSRELA Momentum Accelerates ↗
Via Chartmill
News headline image
Ardelyx Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach ↗
Via MarketBeat
News headline image
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx (ARDX) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx President and CEO Sells 41,000 Shares for $243,000 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Participate in Upcoming Investor Conferences
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx CEO Sells 41k Shares as Company Announces Huge Partnership ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
From Ardelyx, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Ardelyx, Inc. - Common Stock publicly traded?
Yes, Ardelyx, Inc. - Common Stock is publicly traded.
What exchange does Ardelyx, Inc. - Common Stock trade on?
Ardelyx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ardelyx, Inc. - Common Stock?
The ticker symbol for Ardelyx, Inc. - Common Stock is ARDX on the Nasdaq Stock Market
What is the current price of Ardelyx, Inc. - Common Stock?
The current price of Ardelyx, Inc. - Common Stock is 3.780
When was Ardelyx, Inc. - Common Stock last traded?
The last trade of Ardelyx, Inc. - Common Stock was at 09/04/26 04:00 PM ET
What is the market capitalization of Ardelyx, Inc. - Common Stock?
The market capitalization of Ardelyx, Inc. - Common Stock is 389.79M
How many shares of Ardelyx, Inc. - Common Stock are outstanding?
Ardelyx, Inc. - Common Stock has 390M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.